Research funding
Funding research that makes a difference

How we fund research that changes lives
Every year, we invest in high-quality skin research across the UK — from early-stage discovery to large-scale clinical studies.
Our aim is simple: to improve understanding, treatment, and prevention of skin disease, helping people live happier, healthier lives.

Rigorous review. Meaningful impact.
All funding applications go through independent peer review, overseen by leading dermatologists, scientists, and patient representatives.
We ensure every grant supports credible, high-impact research with clear benefits for patients and the dermatology community.
Our approach to research funding
Who we fund
We support researchers in universities, hospitals, and institutes across the UK — from early-career scientists to experienced clinicians.
What we fund
Our grants cover all types of skin disease, including acne, eczema, psoriasis, skin cancer, and rare conditions.
How funding is decided
Applications are reviewed for scientific quality, innovation, and patient benefit, with final recommendations made by our Grants Advisory Committee.
The impact of BSF funding
The British Skin Foundation has played a vital role in funding essential preliminary work that has then progressed to become major national projects. The STOPGAP and PATCH pilot studies are examples of work funded by the BSF which became national studies led by the UK Dermatology Clinical Trials Network, funded by the NIHR.
Professor Hywel Williams, NIHR Senior Investigator and Chair of the UK Dermatology Clinical Trials Network
The British Skin Foundation serves an invaluable role in funding proof of concept studies to enable application for substantial research council grants and in supporting early career researchers.
Professor Chris Griffiths, University of Manchester
The British Skin Foundation has contributed to both the training of next generation non clinical and clinical academics, and breakthroughs in our development of novel and urgently required biomarkers for melanoma as well as novel treatment regimes.
Penny Lovat, Professor of Cellular Dermatology & Oncology, Newcastle University
Help us fund the next breakthrough in skin research
Every discovery begins with support. Your donations make life-changing research possible.